Ken Greenberg

Ken Greenberg

Inversor de Capital Privado en
Venrock Associates
.
Finance
Consumer Services
Commercial Services

Perfil

Ken Greenberg is currently a Partner Partner at Venrock Associates.
Formerly, Dr. Greenberg was Director at Elixir Pharmaceuticals, Inc., Investment Banker at Merrill Lynch Capital Corp., Portfolio Manager at Citadel Advisors LLC from 2020 to 2021, Analyst at Diamondback Capital Management LLC from 2011 to 2012, Principal at MPM BioImpact LLC from 2007 to 2010, Associate at McKinsey & Co., Inc., and Senior Analyst at Ghost Tree Capital LLC from 2013 to 2019.
Education includes an undergraduate degree from Duke University conferred in 1997, a doctorate from the University of Pennsylvania conferred in 2001, and an MBA from The Wharton School of the University of Pennsylvania conferred in 2003.

Cargos activos de Ken Greenberg

EmpresasCargoInicio
Inversor de Capital Privado -

Antiguos cargos conocidos de Ken Greenberg.

EmpresasCargoFin
Gestor de Cartera-Acciones 01/10/2021
Analyst-Equity 01/10/2019
Analyst-Equity 01/12/2012
Inversor de Capital Privado 16/07/2010
Corporate Officer/Principal -
Ver el detalle de la experiencia de Ken Greenberg.

Formación de Ken Greenberg.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

95

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Finance

Finance

Finance

Finance

Finance

Commercial Services

Consumer Services

Consumer Services

Miscellaneous

Finance

Consumer Services